Pembrolizumab induces HIV latency reversal in people living with HIV and cancer on antiretroviral therapy

Author(s):

Thomas S. Uldrick, Scott V. Adams, Remi Fromentin, Michael Roche, Steven P. Fling, Priscila H. Gonçalves, Kathryn Lurain, Ramya Ramaswami, Chia Ching Jackie Wang, Robert J. Gorelick, Jorden L. Welker, Liz O'Donoghue, Harleen Choudhary, Jeffrey D. Lifson, Thomas A. Rasmussen, Ajantha Rhodes, Carolin Tumpach, Robert Yarchoan, Frank Maldarelli, Martin A. Cheever, Rafick Sékaly, Nicolas Chomont, Steven G. Deeks, Sharon R. Lewin

Details:

Science Translational Medicine, Volume 14, Issue 629, 2022-01-26, Article number eabl3836

Article Link: Click here

Affiliations:

• University of Washington
• University of California, San Francisco
• Monash University
• Emory University
• National Cancer Institute (NCI)
• RMIT University
• Aarhus Universitetshospital
• Fred Hutchinson Cancer Center
• Royal Melbourne Hospital
• Centre Hospitalier de L'Université de Montréal
• Leidos Inc.
• Department of Infectious Diseases